CM-Path Recognises the Need for Quality Assurance in Clinical Trials

Dr Clare Verrill organised a meeting on the 21st March 2017 attended by CM-Path members, as well as representatives from the MHRA, Genomics England, industry, clinical trial units, Cancer Research UK and the Experimental Cancer Medicine Centres. Following on from several teleconferences, the day aimed to identify best practice guidance for quality assurance in clinical [...]

By | March 21st, 2017|Whats new|0 Comments

CM-Path and RCPath Host “A Pathologist’s Guide to Research and Clinical Trials”

On December 9th 2016, CM-Path and the Royal College of Pathologists hosted a joint workshop aimed at pathologists that want to gain knowledge of research and clinical trials. Topics included: Using tissue in Clinical Trials – rules and regulations, storage and access - Dr Bridget Wilkins Pathology-based testing of tissues in Clinical Trials – Performance, [...]

By | December 10th, 2016|Uncategorized, Whats new|0 Comments

CM-Path Hosts Industry Engagement Day

On October 5th 2016, CM-Path invited industry representatives from pharmaceutical, molecular diagnostic and digital pathology companies to attend a workshop aimed at identifying solutions and barriers to the uptake of technologies in pathology. The agenda included presentations including: Molecular Diagnostics & the Pharmaceutical Industry - Stephen Hall, Novartis Successful Industry/NHS Collaborations - Dr Angela Silmon, [...]

By | October 10th, 2016|Whats new|0 Comments

The CM-Path Initiative Launches

On June 6th 2016, CM-Path members, funders and NCRI colleagues gathered in London for the intiative's launch. » Download the agenda (PDF) The morning session included presentations from: » Dr Karin Oien (CM-Path Chair) - Introduction to CM-Path (PDF) »Dr Karen Kennedy (NCRI Director) - Introduction to the NCRI (PDF) »Dr Carolyn Chan (CT-Rad Programme [...]

By | June 10th, 2016|Whats new|0 Comments